Codiak Biosciences

Codiak Biosciences

The leader in the emerging field of exosome therapeutics, working to harness the power of this cellular messenger system to create potentially life-changing medicines.

Launch date
Employees
Market cap
€797k
Enterprise valuation
€9m (Public information from Apr 2023)
San Francisco California (HQ)
Authorizing premium user...